The expression of intestinal CYP3A4 in the piglet model

Transplantation Proceedings

Volumn 36, Issue 2, 2004, Pages 361-363

  Nishi, K ^a   Ishii, T ^a   Wada, M ^a   Amae, S ^a   Sano, N ^a   Nio, M ^a   Hayashi, Y ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; BLOOD SAMPLING; CALCULATION; COLON; CONFERENCE PAPER; CONTROLLED STUDY; ILEUM; ILEUM GRAFT; ILEUM RESECTION; IMMUNOHISTOCHEMISTRY; INTESTINE SURGERY; JEJUNUM; MALE; MEASUREMENT; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMALL INTESTINE; SWINE;

ANIMALS; COLON; CYTOCHROME P-450 ENZYME SYSTEM; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; JEJUNUM; SWINE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1642503167     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.12.012     Document Type: Conference Paper

References (11)

1. Sano N., Nio M., Shimaoka S., et al. High trough levels of oral FK506 induced by loss of small intestine. Pediatr Transplant. 5:2001;434.
2. Lown K.S., Ghosh M., Watkins P.B., et al. Sequence of intestinal and hepatic cytochrome P450 3A4 cDNA are identical. Drug Metab Dispos. 26:1998;185.
3. Watkins P.B. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Delivery Rev. 27:1997;161.
4. Lampen A., Christians U., Gonschior A.K., et al. Metabolism of the macrolide immunosuppressant, Tacrolimus, by the pig gut mucosa in the Ussing chamber. Br J Pharmacol. 117:1996;1730.
5. Paine M.F., Khalighi M., Fisher J.M., et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther. 283:1997;1552.
6. Watanabe Y., Sato M., Abe Y., et al. Enteric absorption of FK506: estimation by a block liver perfusion technique in rats. Transplant Proc. 30:1998;3777.
7. Hashida T., Masuda S., Uemoto S., et al. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther. 69:2001;308.
8. Masuda S., Uemoto S., Hashida T., et al. Effect of intestinal P-glycoprotein on daily Tacrolimus trough level in a living-donor small bowel recipient. Clin Pharmacol Ther. 68:2000;98.
9. Floren L.C., Bekersky I., Benet L.Z., et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther. 62:1997;41.
10. Baily D.G., Spence J.D., Munoz C., et al. Interaction of citrus juices with felodipine and nifedipine. Lancet. 337:1991;268.
11. Shimomura M., Masuda S., Saito H., et al. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J Surg Res. 103:2002;215.